"Somos una Institución de Asistencia Privada cuya misión es ofrecer a enfermos de escasos recursos económicos, una atención oftalmológica médica y quirúrgica de alta calidad científica utilizando para ello equipos con tecnología de punta que nos permita ayudar a los pacientes para que se integren a la sociedad lo antes posible. Somos un centro médico líder en la prestación de servicios, en la formación de médicos oftalmólogos generales y especialistas en las diferentes ramas de la oftalmología, estamos desarrollando protocolos de investigación que coadyuven a consolidar los avances de la oftalmología que nos mantengan a la vanguardia de la especialidad."

During the past decade, Asociación para Evitar la Ceguera en Mexico conducted 5 clinical trials. In the 10-year time frame, 5 clinical trials started and 2 clinical trials were completed, i.e. on average, 40% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 2 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asociación para Evitar la Ceguera en Mexico" #1 collaborator was "Emmecell" with 2 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Asociación para Evitar la Ceguera en Mexico" are "Diabetic Macular Edema" (4 trials), "Proliferative Diabetic Retinopathy" (4 trials), "Retinopathy of Prematurity" (2 trials), "Anterior Chamber Deep (ACD)" (1 trials) and "Axial Length (AL)" (1 trials). Many other conditions were trialed in "Asociación para Evitar la Ceguera en Mexico" in a lesser frequency.

Most popular intervention types in "Asociación para Evitar la Ceguera en Mexico" are "Drug" (11 trials), "Procedure" (9 trials), "Device" (5 trials), "Other" (3 trials) and "Biological" (2 trials). Other intervention types were less common.

The name of intervention was led by "Bevacizumab" (2 trials), "EO2002" (2 trials), "Faricimab" (2 trials), "Sham Procedure" (2 trials) and "ALG 1001" (1 trials). Other intervention names were less common.

The vast majority of trials in "Asociación para Evitar la Ceguera en Mexico" are 23 trials for "All" genders.

Currently, there are NaN active trials in "Asociación para Evitar la Ceguera en Mexico". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 10 completed trials in Asociación para Evitar la Ceguera en Mexico, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Asociación para Evitar la Ceguera en Mexico, 5 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 2 trials that are defined as “Not Applicable".